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Across South Asia, traditional communities use
knowledge that has been accumulated over many
generations to treat sickness and improve food
production. Many companies and organizations –
particularly those involved in the pharmaceutical
industry – have become increasingly interested in
such traditional knowledge because it offers the
possibility of a ‘short cut’ to the development of
new foods, drugs and other products.
A recent SANDEE study investigates the economic
incentives that can be used to protect and
sustainably use this traditional knowledge. The
study also looks at how revenues from the utilization
of traditional knowledge can be shared equitably.
Not surprisingly, it finds that both traditional
communities and pharmaceutical companies need
to be confident that they can profit from working
together. However, a number of hurdles can come
in the way of developing workable contracts and
agreements. The study suggests that actual sharing
of the revenues depends, most importantly, on the
relative bargaining strengths of the two parties.
Factors that affect bargaining strengths need to be
taken into account in designing schemes that can
help communities benefit from the use of their
traditional knowledge.
Traditional knowledge has value as a resource base for developing
future biotechnological and pharmaceutical innovations. There has
been a long-running debate on whether traditional knowledge can be
used to profitably identify active compounds for modern medicine – a
process known as pharmaceutical
- or bio-prospecting. While the
current consensus is that
traditional knowledge can help
scientists discover new drugs,
many problems remain. These
include concerns about fair access
to the relevant plant resources,
costs of converting traditional
knowledge to commercial drugs,
and distributing the benefits from
royalties and marketing fees. Such
issues are of import to developing
countries, where much of the
world’s biodiversity and traditional






Traditional knowledge about plant-
based medicines derives much of
its value from its current use around
the world. The World Health
Organization, for instance,
estimates that close to 80% of the
population in developing countries
depends on traditional medicine in
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one form or the other. In many
developed and developing
economies traditional herbal and
other plant-based remedies are




involved in plant-based drugs
research are interested in traditional
knowledge as an information
source for two reasons: (a) it
provides valuable leads in the
search for active compounds that
could be used to produce
pharmaceutical drugs; and (b), it
can help develop entirely new plant-
based pharmaceutical drugs by
highlighting the medicinal
properties of plants that had
previously been unknown outside
a community or region.
Pharmaceutical research and
development often involves many
years of work and considerable
financial investment. Because
traditional knowledge about
medicinal plants can increase the
‘hit rate’ in the process of
identifying active compounds it can
save time and money. With the
growth in biotechnology research,
traditional knowledge no longer
represents a relic from the past that
needs to be preserved for its
intrinsic and aesthetic values.
Instead, it is seen as a rich source
of raw material for new innovations.
Traditional knowledge about nature
and its uses is held collectively and
it is not new. In almost all cases,
such knowledge is preserved and
util ized only through inter-
generational transfer within the members of a specific community.  There
are no pre-existing patents or other intellectual property rights that can
protect it. Thus, when it comes to sharing traditional knowledge, a key
challenge is to ensure that a fair bargaining process takes place between
communities and bio-prospecting companies. The need for equitable
bargaining systems gains importance in the light of declining transfer
and use of traditional knowledge.  This study, undertaken by K. Aparna
Bhagirathy, is motivated by concerns about the depletion of traditional
knowledge and recent efforts to preserve this knowledge through
commercial use.
INVESTIGATING BIO-PROSPECTING
Bhagirathy investigates how communities and companies might agree
to share traditional knowledge.  She looks at incentives that can induce
companies to invest in bio-prospecting and persuade traditional
communities to share their knowledge. The study asks two key questions:
(1) under what conditions do communities and pharmaceutical
companies enter into contracts to develop traditional-knowledge-based
innovations? And, (2) what factors influence the way in which the
benefits from the commercial use of traditional knowledge are shared
between these two parties?
To find the answers to these questions, Bhagirathy examines a
hypothetical situation in which there are only two economic agents -
Agent 1 represents a community that holds traditional knowledge and
Agent 2 represents a pharmaceutical company with the technology to
develop an innovation based on this knowledge. The study examines
profit-sharing agreements between the two agents with the help of an
economic model based on a game-theoretic framework.
TESTING DIFFERENT BARGAINING SCENARIOS
Bhagirathy uses a bargaining model to analyze a number of different
scenarios. First, she assumes that both the community and the company
are fully informed about the potential costs and revenues associated
with their collaboration. However, this assumption rarely holds in practice.
While traditional communities possess knowledge about plant resources,
pharmaceutical companies are better informed about the potential costs
and benefits associated with the development of drugs based on this
knowledge.  As a result, the expectations regarding future revenue streams
from the application of traditional knowledge are likely to be different for
these two groups. Thus, Bhagirathy then assesses the impact of this





Traditional knowledge is rarely
documented.  It is preserved by means
of oral transfer from one generation to
the next. However, as traditional
communities come into contact with
outside influences, the use of traditional
knowledge often declines and with it the
transfer of the knowledge from one
generation to the next. This means that in
many parts of the world, traditional
knowledge about the use of plant
resources is in danger of being lost forever.
In the last two decades, various rules and
regulations have been formulated to try
and protect traditional knowledge and also
to help communities to gain from their
knowledge.  At the international level, there
are multilateral agreements and guiding
principles, such as The Convention on
Biological Diversity, which lay down a
framework for the sustainable use of
biological resources and any associated
traditional knowledge and practices. At the
national level, countries have incorporated
specific provisions into their intellectual
property laws and established what have
come to be known as sui generis systems.
These measures define explicit provisions
that govern the sharing and usage of
traditional knowledge. At a more local level,
during the nineties, several
pharmaceutical companies and research
organizations developed benefit-sharing
contracts with traditional communities in
the course of ethno-botanical research.
It is clear that such contracts – if they are
fair and well managed – offer a strong
incentive for communities to preserve their
traditional knowledge.
The paper analyses separate individual profit maximization strategies, as
well as a cooperative strategy for joint profit maximization. In the process,
several contract structures involving the payment of royalties, fixed license
fees or a combination of both are considered.  Different types of activities
in the various stages of the bio-prospecting cycle (such as whether
traditional communities are involved in plant collecting) are also assessed.
Finally a situation is analyzed in which an outsider, such as the
government or a NGO, is involved.
WHAT MAKES BIO-PROSPECTING WORK?
It is clear that communities and companies will only be interested in
entering into a contract to develop drugs based on traditional knowledge
if both the parties can earn profits that are at least equal to their costs.
The actual sharing of these profits depends on the relative bargaining
strengths of the two partners.   Factors that affect relative bargaining
strengths include the contribution each party makes in the process of
developing a medical innovation, the availability of alternative plant
resources and information, differences in expectations relating to future
revenues and costs, and the involvement of a third party in the
negotiations. Each of these factors has a different impact on the final
sharing of profits. For instance, under conditions of joint profit
maximization, the community has a stronger bargaining position if it
supplies the plant resources as well as sharing its knowledge. However, if
the company is able to synthesize the compound in the laboratory or if it
finds an alternative source, then the community loses some of its
bargaining power.
SANDEE | P.O.Box 8975 EPC-1056 | Kathmandu, Nepal





This policy brief is an output of a re-
search project funded by SANDEE. The
view’s expressed here are not neces-
sarily those of SANDEE’s sponsors.
SANDEE
The South Asian Network for
Development and Environmental
Economics (SANDEE) is a regional
network that seeks to bring together
analysts from the different countries
in South Asia to address their
development-environment problems.
Its mission is to strengthen the
capacity of individuals and
institutions in South Asia to undertake
research on the inter-linkages among
economic development, poverty, and
environmental change, and, to
disseminate practical information that
can be applied to development
policies. SANDEE’s activities cover
Bangladesh, Bhutan, Nepal, India,
Pakistan and Sri Lanka.
SANDEE’s Policy Brief Series seek to in-
form a wide and general audience about








HOW TO MAKE BIO-PROSPECTING FAIRER
Past efforts at bio-prospecting have shown that, in dealings between
traditional communities and bio-prospecting companies, most
complications arise in the identification of stakeholders and sharing of
profits. A careful understanding of the negotiating positions, bargaining
strengths, and asymmetries of expectations of both traditional
communities and pharmaceutical companies can definitely mitigate
some of these problems. Such an understanding can also help strengthen
intellectual property rights related to traditional knowledge.
A lot more information is needed on how to design incentives and
contractual arrangements that would guarantee that all parties involved
in the bio-prospecting business are treated fairly. This paper identifies a
set of conditions that need to be empirically tested.  Such research is
vital since many developing nations are now taking steps, in terms of
legislation and programs, to conserve and promote biodiversity and
associated traditional knowledge.
